J&J Medical Connect
SPRAVATO®

(esketamine)

+ Save link
J&J Medical Connect

Connect with us

Connect with us

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

SPRAVATO® (esketamine)

Medical Information

Use of SPRAVATO in Patients with Comorbid Parkinson’s Disease

Last Updated: 11/14/2025

SUMMARY  

  • SPRAVATO is not indicated for the treatment of Parkinson’s disease.
  • Clinical studies designed to evaluate the efficacy and/or safety of SPRAVATO in patients with Parkinson’s disease have not been performed.

Literature Search

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, DERWENT® (and/or other resources, including internal/external databases) conducted on 04 November 2025 did not identify any relevant citations pertaining to this topic.